NCT02468193 2020-05-06Study of Efficacy and Safety of Osilodrostat in Cushing's SyndromeNovartisPhase 2 Completed9 enrolled 22 charts
NCT02804750 2019-10-15Study to Evaluate CORT125134 in Participants With Cushing's SyndromeCorcept TherapeuticsPhase 2 Completed35 enrolled 13 charts
NCT00958841 2016-07-26Study of Pasireotide in Patients With Rare Tumors of Neuroendocrine OriginNovartisPhase 2 Terminated118 enrolled 11 charts
NCT00936741 2014-04-02An Extension Study of CORLUX in the Treatment of Endogenous Cushing's SyndromeCorcept TherapeuticsPhase 3 Completed30 enrolled 8 charts
NCT01371565 2014-03-18Compassionate Use of CORLUX® (Mifepristone) in the Treatment of Signs and Symptoms of Endogenous Cushing's SyndromeCorcept TherapeuticsPhase 3 Completed4 enrolled 7 charts